Publication|Articles|September 13, 2024
- Applied Clinical Trials-09-01-2024
- Volume 33
- Issue 9
Applied Clinical Trials September 2024 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials September 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 2 years ago
Aligning Technology and Oversightalmost 2 years ago
A New Regulatory Road in Clinical Trials: Digital Twinsalmost 2 years ago
Bridging Patient Support Gaps While Navigating Global Regulationsalmost 2 years ago
Regulatory CMC: Enhancing Biologics Developmentalmost 2 years ago
In Focus: Top Takeaways from FDA Final Guidance on Real-World Evidencealmost 2 years ago
Driving Inclusion in Clinical Trials: Less Talk, More Trustalmost 2 years ago
Risk Planning: A Review of Industry Trendsabout 2 years ago
An Overview of FDA Diversity-Related Documents for Clinical TrialsAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
2
Data Quality Across the Clinical Trial Lifecycle: What It Takes to Fully Trust Your Data
3
ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps
4
The CRA of the Future: From Monitoring Activity to Strategic Site Partnership
5